Effect of a Mindfulnes Program "Healthy Under Stress" on Stress: A Prospective Intervention Study
Launched by UNIVERSITY HOSPITAL TUEBINGEN · May 23, 2024
Trial Information
Current as of February 19, 2025
Not yet recruiting
Keywords
ClinConnect Summary
After baseline (t0), all participant will receive the following intervention:
The intervention lasts eight weeks, with a two-hour session held once a week. The selected topics include nutrition, mindfulness, exercise, relaxation techniques, dealing with stressors, effective communication and the promotion of a supportive social network.
t1 (at the end of the program).
t2 (3 months after t0).
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Employees, patients and family members of the Robert-Bosch-Krankenhaus (RBK) and Bosch Health Campus of all specialties.
- • Informed consent.
- Exclusion Criteria:
- • Physical or mental condition which, in the opinion of the investigator does not allow the patient to participate in the study.
- • Participation in other clinical studies with behavioral, psychological or complementary medical interventions.
- • Insufficient knowledge of the German language.
Trial Officials
Marcela Winkler, Dr
Study Director
Robert Bosch Gesellschaft für Medizinische Forschung mbH
About University Hospital Tuebingen
University Hospital Tübingen is a leading academic medical institution in Germany, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, the hospital leverages its multidisciplinary expertise and cutting-edge facilities to develop new therapeutic strategies and improve patient outcomes. With a strong focus on translational medicine, University Hospital Tübingen collaborates with various stakeholders, including pharmaceutical companies and research organizations, to facilitate the efficient and ethical conduct of trials across a wide range of medical disciplines. Their dedication to patient-centered research and rigorous scientific standards positions them at the forefront of medical advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Stuttgart, Baden Würtenberg, Germany
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0